TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.

Priyanka Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.